11th European AIDS Conference / EACS
Webcasted Presentation

Search’n Build™
Search presentations by keyword and instantly build your own highlight of the conference!


Switching from Combivir[CBV] (AZT/3TC) to Truvada [TVD] (Tenofovir DF/FTC) Maintains Viral Suppression, Prevents and Reverses Limb Fat Loss, and Improves Biochemical Parameters: Results of a 48 Week Randomised Study
Martin Fisher, United Kingdom    - Biography
English - 2007-10-25
 
Speaker Disclosure
Gilead Sciences Study, Granta Park, Abington, CAMBS CB21 GGT UK
  ( 16 slide(s) )